Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail
(NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Rodeo™ Telescopic Nail.
- (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Rodeo™ Telescopic Nail.
- View the full release here: https://www.businesswire.com/news/home/20240509384510/en/
The Rodeo Telescopic Nail by Orthofix is an innovative device to surgically treat deformities or fractures in patients suffering from osteogenesis imperfecta. - (Photo: Business Wire)
The Rodeo Telescopic Nail is an innovative device indicated to surgically treat deformities or fractures in patients suffering from osteogenesis imperfecta (OI). - The Rodeo system is designed to address many of the biomechanical and procedural challenges associated with current OI telescopic rod systems.